应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
00512 远大医药
已收盘 01-12 16:08:30
7.750
-0.150
-1.90%
最高
7.950
最低
7.720
成交量
1,066万
今开
7.930
昨收
7.900
日振幅
2.91%
总市值
275.09亿
流通市值
275.09亿
总股本
35.50亿
成交额
8,288万
换手率
0.30%
流通股本
35.50亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
两大重磅首仿,三家药企上市受挫!
摩熵医药 · 01-08
两大重磅首仿,三家药企上市受挫!
每日卖空追踪 | 远大医药 01月08日卖空量成交18.6万股,卖空比例为4.14%
市场透视 · 01-08
每日卖空追踪 | 远大医药 01月08日卖空量成交18.6万股,卖空比例为4.14%
远大医药01月08日主力净流出476.1万元 散户资金买入
市场透视 · 01-08
远大医药01月08日主力净流出476.1万元 散户资金买入
每日卖空追踪 | 远大医药 01月06日卖空量成交7.4万股,卖空比例为1.33%
市场透视 · 01-06
每日卖空追踪 | 远大医药 01月06日卖空量成交7.4万股,卖空比例为1.33%
远大医药01月06日获主力加仓6.6万元
市场透视 · 01-06
远大医药01月06日获主力加仓6.6万元
恒瑞医药、远大医药等创新药密集突破,将重塑前列腺癌诊疗格局
制药网 · 01-06
恒瑞医药、远大医药等创新药密集突破,将重塑前列腺癌诊疗格局
创新产品四连击,远大医药(00512)产品生态进入收获期,全球布局开启发展新篇章
智通财经 · 01-05
创新产品四连击,远大医药(00512)产品生态进入收获期,全球布局开启发展新篇章
远大医药旗下湖北远大拟收购河北远大九孚生物科技及保定嘉和精细化工
美股速递 · 2025-12-31
远大医药旗下湖北远大拟收购河北远大九孚生物科技及保定嘉和精细化工
再拓版图!远大医药(00512)战略性并购深化氨基酸核心竞争优势,夯实产业龙头地位
智通财经 · 2025-12-31
再拓版图!远大医药(00512)战略性并购深化氨基酸核心竞争优势,夯实产业龙头地位
每日卖空追踪 | 远大医药 12月30日卖空量成交43.25万股,卖空比例为10.12%
市场透视 · 2025-12-30
每日卖空追踪 | 远大医药 12月30日卖空量成交43.25万股,卖空比例为10.12%
远大医药12月30日主力净流入297.2万元 散户资金抛售
市场透视 · 2025-12-30
远大医药12月30日主力净流入297.2万元 散户资金抛售
礼来卷爆减肥药赛道
北海茶客投研笔记 · 2025-12-30
礼来卷爆减肥药赛道
众强药业完成B轮近亿元融资,加速核心产品研发进程
药研界面 · 2025-12-30
众强药业完成B轮近亿元融资,加速核心产品研发进程
远大医药(00512)多板块里程碑式突破:深耕核药“诊疗一体化”闭环,多板块齐开花铸造创新增长极
智通财经 · 2025-12-30
远大医药(00512)多板块里程碑式突破:深耕核药“诊疗一体化”闭环,多板块齐开花铸造创新增长极
远大医药(00512)引进的全球首款用于治疗严重过敏反应的肾上腺素鼻喷雾剂获颁发药品注册证书
智通财经 · 2025-12-29
远大医药(00512)引进的全球首款用于治疗严重过敏反应的肾上腺素鼻喷雾剂获颁发药品注册证书
每日卖空追踪 | 远大医药 12月24日卖空量成交16.6万股,卖空比例为11.37%
市场透视 · 2025-12-24
每日卖空追踪 | 远大医药 12月24日卖空量成交16.6万股,卖空比例为11.37%
智通港股早知道 | 铜价触及新高突破12000美元 第六批国家高价值耗材集采启动
智通财经 · 2025-12-24
智通港股早知道 | 铜价触及新高突破12000美元 第六批国家高价值耗材集采启动
远大医药(00512)引进全球首款用于治疗严重过敏反应的肾上腺素鼻喷雾剂
智通财经 · 2025-12-23
远大医药(00512)引进全球首款用于治疗严重过敏反应的肾上腺素鼻喷雾剂
每日卖空追踪 | 远大医药 12月22日卖空量成交17.2万股,卖空比例为4.51%
市场透视 · 2025-12-22
每日卖空追踪 | 远大医药 12月22日卖空量成交17.2万股,卖空比例为4.51%
远大医药12月22日获主力加仓94.0万元
市场透视 · 2025-12-22
远大医药12月22日获主力加仓94.0万元
加载更多
公司概况
公司名称:
远大医药
所属市场:
SEHK
上市日期:
--
主营业务:
远大医药健康控股有限公司是一家主要从事制造及销售医药制剂及医疗器械的香港投资控股公司。该公司主要从事制造及销售医药制剂及医疗器械、生物技术产品及营养产品、精品原料药和其他产品。该公司的主要产品涵盖抗肿瘤、心血管急救制剂及高端心脑血管介入医疗器械、抗病毒抗感染、呼吸及五官科以及生物健康产品和精品原料药。
发行价格:
--
{"stockData":{"symbol":"00512","market":"HK","secType":"STK","nameCN":"远大医药","latestPrice":7.75,"timestamp":1768205310002,"preClose":7.9,"halted":0,"volume":10663500,"delay":0,"floatShares":3549571148,"shares":3549571148,"eps":0.704885,"marketStatus":"已收盘","change":-0.15,"latestTime":"01-12 16:08:30","open":7.93,"high":7.95,"low":7.72,"amount":82884964,"amplitude":0.029114,"askPrice":7.77,"askSize":67000,"bidPrice":7.75,"bidSize":6000,"shortable":3,"etf":0,"ttmEps":0.594325,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1768267800000},"marketStatusCode":5,"adr":0,"listingDate":819302400000,"exchange":"SEHK","adjPreClose":7.9,"dividendRate":0.033548,"openAndCloseTimeList":[[1768181400000,1768190400000],[1768194000000,1768204800000]],"volumeRatio":1.623181,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/00512","defaultTab":"news","newsList":[{"id":"2602089341","title":"两大重磅首仿,三家药企上市受挫!","url":"https://stock-news.laohu8.com/highlight/detail?id=2602089341","media":"摩熵医药","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602089341?lang=zh_cn&edition=full","pubTime":"2026-01-08 21:06","pubTimestamp":1767877570,"startTime":"0","endTime":"0","summary":"目前,布立西坦口服溶液仅有江西科睿药业一家药企报产在审。2026年1月6日,山东朗诺制药的口腔崩解片和 远大医药 的片剂上市申请相继折戟;而早在2025年12月29日,已有5家企业的比拉斯汀片上市申请被拒。截至目前有15家药企上市申请未被批准。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260108211840a7033951&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260108211840a7033951&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["00512","BK1191","01477","BK1574"],"gpt_icon":0},{"id":"2602417733","title":"每日卖空追踪 | 远大医药 01月08日卖空量成交18.6万股,卖空比例为4.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2602417733","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602417733?lang=zh_cn&edition=full","pubTime":"2026-01-08 16:30","pubTimestamp":1767861014,"startTime":"0","endTime":"0","summary":"远大医药北京时间01月08日,跌2.11%,卖空量成交18.6万股,较上一交易日减少76.03%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260108164340a4ab40d1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260108164340a4ab40d1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","00512"],"gpt_icon":0},{"id":"2602341794","title":"远大医药01月08日主力净流出476.1万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2602341794","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602341794?lang=zh_cn&edition=full","pubTime":"2026-01-08 16:15","pubTimestamp":1767860156,"startTime":"0","endTime":"0","summary":"01月08日, 远大医药股价跌2.11%,报收7.90元,成交金额3563.5万元,换手率0.13%,振幅2.48%,量比0.76。远大医药今日主力资金净流出476.1万元,上一交易日主力净流入120.8万元。该股近5个交易日上涨0.64%,主力资金累计净流出968.5万元;近20日主力资金累计净流出2595.8万元,其中净流出天数为10日。该股主力净额占比0.02%,港股市场排名2457/2713。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260108162716a7022893&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260108162716a7022893&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","00512"],"gpt_icon":0},{"id":"2601897035","title":"每日卖空追踪 | 远大医药 01月06日卖空量成交7.4万股,卖空比例为1.33%","url":"https://stock-news.laohu8.com/highlight/detail?id=2601897035","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601897035?lang=zh_cn&edition=full","pubTime":"2026-01-06 16:30","pubTimestamp":1767688212,"startTime":"0","endTime":"0","summary":"远大医药北京时间01月06日,涨0.63%,卖空量成交7.4万股,较上一交易日减少93.85%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260106163144a6f980bd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260106163144a6f980bd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","00512"],"gpt_icon":0},{"id":"2601063897","title":"远大医药01月06日获主力加仓6.6万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2601063897","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601063897?lang=zh_cn&edition=full","pubTime":"2026-01-06 16:16","pubTimestamp":1767687362,"startTime":"0","endTime":"0","summary":"01月06日, 远大医药股价涨0.63%,报收8.04元,成交金额4441.2万元,换手率0.16%,振幅2.25%,量比1.00。远大医药今日主力资金净流入6.6万元,上一交易日主力净流入14.9万元。该股近5个交易日上涨2.16%,主力资金累计净流出1285.3万元,其中1个交易日为股价下跌时净流入;近20日主力资金累计净流出1920.5万元,其中净流出天数为9日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260106162307a6f976d3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260106162307a6f976d3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["00512","BK1191"],"gpt_icon":0},{"id":"2601098897","title":"恒瑞医药、远大医药等创新药密集突破,将重塑前列腺癌诊疗格局","url":"https://stock-news.laohu8.com/highlight/detail?id=2601098897","media":"制药网","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601098897?lang=zh_cn&edition=full","pubTime":"2026-01-06 10:37","pubTimestamp":1767667064,"startTime":"0","endTime":"0","summary":"前列腺癌已成为威胁全球男性健康的主要恶性肿瘤之一,在我国的发病率亦呈持续攀升态势。据数据显示,2022年中国前列腺癌新发病例数约达13.42万人,药物需求迫切。近期,恒瑞医药、远大医药等国内药企相继在前列腺癌领域传来研发进展,为国内患者带来新的治疗希望。本次临床试验的批准标志着恒瑞医药在前列腺癌治疗领域的产品管线布局取得重要进展。在前列腺癌诊断领域,远大医药的创新放射性核素偶联药物取得关键突破。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260106104202a4a14741&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260106104202a4a14741&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","LU1023057109.AUD","LU2543165471.USD","LU0359201885.HKD","06978","LU0359201612.USD","BK1161","00512","01276","LU0359202008.SGD","BK1191"],"gpt_icon":0},{"id":"2601075783","title":"创新产品四连击,远大医药(00512)产品生态进入收获期,全球布局开启发展新篇章","url":"https://stock-news.laohu8.com/highlight/detail?id=2601075783","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601075783?lang=zh_cn&edition=full","pubTime":"2026-01-05 09:43","pubTimestamp":1767577410,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,2025年末,远大医药接连亮出多款创新产品新进展,覆盖核药、中药抗抑郁以及急救等前沿治疗领域,全面展现了公司“自研+引进”创新战略布局成效。TLX591-CDx的引进及其在国内III期临床的成功,正是公司“全球引进”战略高效落地的典范。在研发及产品之外,远大医药的全产业链布局,为其在高壁垒、高增长的核药黄金赛道上持续领跑提供了有力保障。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1388456.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"创新产品四连击,远大医药(00512)产品生态进入收获期,全球布局开启发展新篇章","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1191","00512"],"gpt_icon":0},{"id":"1142637906","title":"远大医药旗下湖北远大拟收购河北远大九孚生物科技及保定嘉和精细化工","url":"https://stock-news.laohu8.com/highlight/detail?id=1142637906","media":"美股速递","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1142637906?lang=zh_cn&edition=full","pubTime":"2025-12-31 16:53","pubTimestamp":1767171221,"startTime":"0","endTime":"0","summary":"远大医药集团宣布,其附属公司湖北远大医药有限公司计划收购河北远大九孚生物技术有限公司以及保定嘉和精细化工有限公司的股权。\n此次收购旨在进一步整合产业链资源,强化公司在生物医药及精细化工领域的战略布局。河北远大九孚生物科技专注于生物技术研发,而保定嘉和精细化工则在医药中间体及特种化学品领域具备技术优势。\n通过本次交易,远大医药有望提升产品协同效应,增强市场竞争力,并为长期业务增长注入新动力。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00512","BK1191"],"gpt_icon":0},{"id":"2595372227","title":"再拓版图!远大医药(00512)战略性并购深化氨基酸核心竞争优势,夯实产业龙头地位","url":"https://stock-news.laohu8.com/highlight/detail?id=2595372227","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2595372227?lang=zh_cn&edition=full","pubTime":"2025-12-31 16:50","pubTimestamp":1767171039,"startTime":"0","endTime":"0","summary":"作为全球氨基酸生产和消费大国,我国在全球氨基酸产业中占据着重要位置。此次收购事项,正是公司践行核心经营理念的重要战略举措,也将进一步巩固公司在氨基酸业务上的产品及产业链优势。通过本次收购,相关产品后续将纳入远大医药,进一步完善公司特色氨基酸产品管线,强化高质量氨基酸的产品布局,助力公司深化多元化氨基酸延伸的战略。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1387727.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"再拓版图!远大医药(00512)战略性并购深化氨基酸核心竞争优势,夯实产业龙头地位","news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1191","00512"],"gpt_icon":0},{"id":"2595119437","title":"每日卖空追踪 | 远大医药 12月30日卖空量成交43.25万股,卖空比例为10.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2595119437","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2595119437?lang=zh_cn&edition=full","pubTime":"2025-12-30 16:30","pubTimestamp":1767083412,"startTime":"0","endTime":"0","summary":"远大医药北京时间12月30日,涨1.4%,卖空量成交43.25万股,较上一交易日减少41%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251230163110a4897b32&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251230163110a4897b32&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["00512","BK1191"],"gpt_icon":0},{"id":"2595711974","title":"远大医药12月30日主力净流入297.2万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2595711974","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2595711974?lang=zh_cn&edition=full","pubTime":"2025-12-30 16:16","pubTimestamp":1767082560,"startTime":"0","endTime":"0","summary":"12月30日, 远大医药股价涨1.40%,报收7.98元,成交金额3410.1万元,换手率0.12%,振幅2.80%,量比0.94。远大医药今日主力资金净流入297.2万元,上一交易日主力净流出969.2万元。该股近5个交易日下跌3.17%,主力资金累计净流入67.3万元;近20日主力资金累计净流出632.7万元,其中净流出天数为9日。该股主力净额占比0.01%,港股市场排名314/2706。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251230162257a6e070c2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251230162257a6e070c2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","00512"],"gpt_icon":0},{"id":"2595764263","title":"礼来卷爆减肥药赛道","url":"https://stock-news.laohu8.com/highlight/detail?id=2595764263","media":"北海茶客投研笔记","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2595764263?lang=zh_cn&edition=full","pubTime":"2025-12-30 14:59","pubTimestamp":1767077951,"startTime":"0","endTime":"0","summary":"礼来的销售人员说自己看到这个的时候就惊讶了一下,这是要把这个赛道卷爆了。GLP-1赛道,卒于25年末。中集集团近日在投资者互动平台上表示,集团子公司中集安瑞科在低温特种装备领域拥有深厚技术积累,能够提供包括燃料运输、储存、加注系统在内的关键装备,已成为多个商业航天公司的配套服务商。年内中集安瑞科为客户的商业航天项目提供了9台大型低温液氧储罐。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251230151157a4892931&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251230151157a4892931&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2417539215.USD","LU1267930730.SGD","LU1868836591.USD","LU0154236417.USD","LU0456855351.SGD","LU0787776722.HKD","IE00BKVL7J92.USD","LU0122379950.USD","BK4516","IE00B1XK9C88.USD","LU0316494557.USD","LU0471298694.HKD","LU0006306889.USD","LU0820561818.USD","LU1974910355.USD","LU2265009873.SGD","LU2552382058.USD","SG9999018865.SGD","IE0004445015.USD","IE00BKDWB100.SGD","LU1989771016.USD","SGXZ31699556.SGD","LU2750360641.GBP","LU2063271972.USD","IE00BFTCPJ56.SGD","LU2168564149.EUR","LU2106854487.HKD","LU2746668461.USD","LU1064131342.USD","LU2361045086.USD","LU0289739699.SGD","LU0466842654.USD","NVO","LU0114720955.EUR","IE00BZ1G4Q59.USD","LU0256863811.USD","IE0009355771.USD","LU2324357040.USD","IE00B775H168.HKD","LU2461242641.AUD","LU2237443978.SGD","LU0079474960.USD","LU1093756168.USD","LU1623119135.USD","SG9999014906.USD","SGXZ51526630.SGD","00512","IE0005OL40V9.USD","LU0061475181.USD","03750","LU2112291526.USD","LLY","IE00BKPKM429.USD","LU2168564065.EUR","LU2211815571.USD","LU0320765059.SGD","LU0708995401.HKD","LU0353189680.USD","IE00BJLML261.HKD","BK4007","LU0823434740.USD","LU1069344957.HKD","LU0943347566.SGD","LU2456880835.USD","IE00B1BXHZ80.USD","SG9999013999.USD","IE00BN29S564.USD","LU2237438978.USD","LU2168564222.USD","IE00BFSS7M15.SGD","LU1366192091.USD","LU0882574055.USD","LU1868836914.USD","IE00BK4W5M84.HKD","LU1804176565.USD","IE00BJT1NW94.SGD","LU0058720904.USD","LU1093756325.SGD","LU0820561909.HKD","LU1712237335.SGD","IE00B7KXQ091.USD","BK4581","SGXZ99366536.SGD","LU2357305700.SGD","IE00B2B36J28.USD","LU2746668974.SGD","LU1127390331.HKD","LU1720051017.SGD","BK4532","LU1280957306.USD","LU2471134523.USD","LU0471298777.SGD","LU1551013425.SGD","LU2360106947.USD","LU2471134796.USD","BK4534","SG9999018857.SGD","IE00BFSS8Q28.SGD","SGXZ81514606.USD","GB00BDT5M118.USD","SGXZ57979304.SGD","LU0234572021.USD","IE00BK4W5L77.USD","LU2236285917.USD","LU0096364046.USD","LU2237443465.HKD","LU0353189763.USD","IE00BJJMRZ35.SGD","LU1323610961.USD","SG9999015978.USD","IE0004445239.USD","IE00B4R5TH58.HKD","BK4533","LU2168564495.EUR","LU1548497426.USD","LU0354030511.USD","LU2361044949.HKD","IE00BWXC8680.SGD","LU0266013472.USD","LU0640476718.USD","LU1868837136.USD","LU2602419157.SGD","SG9999017495.SGD","LU0203202063.USD","LU0320765992.SGD","LU1035775433.USD","LU2237443549.SGD","LU2264538146.SGD","SG9999014914.USD","LU0198837287.USD","LU0256863902.USD","LU2552382215.SGD","LU0354030438.USD","LU2750360997.AUD","LU2023250504.SGD","LU0689472784.USD","LU0823416689.USD","SG9999015945.SGD","SG9999015986.USD","LU0683600562.USD","LU1988902786.USD","LU2471134879.HKD","LU0823434583.USD","IE00B4JS1V06.HKD","LU2491050071.SGD","LU2237443895.HKD","LU2108987350.USD","LU1023059063.AUD","SG9999014880.SGD","LU1061106388.HKD","LU0109394709.USD","LU0432979614.USD","LU0323591593.USD","IE00BJJMRX11.SGD","LU2089984988.USD","LU1057294990.SGD","LU2087625088.SGD","LU0786609619.USD","LU1551013342.USD","LU2491050154.USD","LU2237443382.USD","BK4585","LU0385154629.USD","LU2237443622.USD","IE00BJJMRY28.SGD","LU0097036916.USD","BK4588","LU0203201768.USD","LU2468319806.SGD","LU0238689110.USD","LU1917777945.USD","LU0106261372.USD","LU2552382132.HKD","LU1291159041.SGD","IE0002141913.USD","SG9999001176.SGD","LU0109391861.USD","LU2168563687.JPY","LU2471134952.CNY","LU1868837300.USD","LU1983299246.USD","LU1868836757.USD","LU0882574139.USD","BK4599","SG9999015952.SGD","LU0889565916.HKD","LU1814569148.SGD","LU0094547139.USD","LU2462157665.USD","SG9999014898.SGD","03899","LU0417517546.SGD","LU0672654240.SGD","LU2491049909.HKD","SG9999001176.USD","LU1720051108.HKD","LU1232071149.USD","LU2361044865.SGD"],"gpt_icon":1},{"id":"2595371190","title":"众强药业完成B轮近亿元融资,加速核心产品研发进程","url":"https://stock-news.laohu8.com/highlight/detail?id=2595371190","media":"药研界面","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2595371190?lang=zh_cn&edition=full","pubTime":"2025-12-30 11:41","pubTimestamp":1767066064,"startTime":"0","endTime":"0","summary":"同时,众强药业与远大医药就公司核心产品,针对用于治疗肺动脉高压的曲前列尼尔系列产品达成CSO合作,共同推进该系列产品的市场商业化,目前该系产品已取得卓越商业化进展。与远大医药的CSO合作将极大加速公司核心产品的商业化进程,让公司的创新成果更快惠及患者。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251230115555a48890fd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251230115555a48890fd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","00512"],"gpt_icon":0},{"id":"2595684754","title":"远大医药(00512)多板块里程碑式突破:深耕核药“诊疗一体化”闭环,多板块齐开花铸造创新增长极","url":"https://stock-news.laohu8.com/highlight/detail?id=2595684754","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2595684754?lang=zh_cn&edition=full","pubTime":"2025-12-30 09:00","pubTimestamp":1767056422,"startTime":"0","endTime":"0","summary":"当前,全球核药抗肿瘤诊疗领域正以前所未有的速度迈向“诊疗一体化”时代。远大医药计划于年内在中国递交新药上市申请,将有望为中国前列腺癌患者提供一种更精准、高效的诊断新标准。亮眼的业绩不仅验证了该产品的临床价值,更证明了远大医药“诊疗一体化”组合策略在全球范围内的核心竞争力。面对如此规模的蓝海,该领域的核药“诊疗一体化”已成为巨头竞逐的核心赛道。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1386850.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["00512","BK1191"],"gpt_icon":0},{"id":"2595858157","title":"远大医药(00512)引进的全球首款用于治疗严重过敏反应的肾上腺素鼻喷雾剂获颁发药品注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2595858157","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2595858157?lang=zh_cn&edition=full","pubTime":"2025-12-29 17:04","pubTimestamp":1766999087,"startTime":"0","endTime":"0","summary":"智通财经APP讯,远大医药 发布公告,近日,本集团通过与祐儿医药合作获得的全球首款用于紧急治疗成人和 30kg 及以上儿童患者I型过敏反应的肾上腺素鼻喷雾剂Neffy (优敏速)获得中国国家药品监督管理局颁发药品注册证书,本集团拥有该产品在中国大陆合作渠道内的独家商业化权益以及在中国香港特别行政区的非独家商业化权益,并计划在产品获批后的24个月之内实现本地化生产。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1386536.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":"远大医药(00512)引进的全球首款用于治疗严重过敏反应的肾上腺素鼻喷雾剂获颁发药品注册证书","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["00512","BK1191"],"gpt_icon":0},{"id":"2594040282","title":"每日卖空追踪 | 远大医药 12月24日卖空量成交16.6万股,卖空比例为11.37%","url":"https://stock-news.laohu8.com/highlight/detail?id=2594040282","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2594040282?lang=zh_cn&edition=full","pubTime":"2025-12-24 16:30","pubTimestamp":1766565012,"startTime":"0","endTime":"0","summary":"远大医药北京时间12月24日,跌2.65%,卖空量成交16.6万股,较上一交易日减少63.31%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251224163120a6c98125&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251224163120a6c98125&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["00512","BK1191"],"gpt_icon":0},{"id":"2593444998","title":"智通港股早知道 | 铜价触及新高突破12000美元 第六批国家高价值耗材集采启动","url":"https://stock-news.laohu8.com/highlight/detail?id=2593444998","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593444998?lang=zh_cn&edition=full","pubTime":"2025-12-24 07:28","pubTimestamp":1766532494,"startTime":"0","endTime":"0","summary":"铜价触及新高突破12,000美元 关税政策搅动市场格局贵金属牛市持续,黄金、白银、铜、铂金齐创新高。铜价触及历史新高,突破每吨12,000美元,因矿山严重停产及美国总统特朗普关税政策引发的贸易紊乱,使这种关键工业金属有望创下2009年以来最大年度涨幅。伦敦金属交易所期铜一度突破每吨12000美元,达到12044美元,延续了今年以来累计上涨约37%的涨势。这也是第六批高值医用耗材国家集采。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"e73e0d3a45118b08177935e11ac95a86","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1385231.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1169","00357","BK1191","00228","BK1154","LU1983299162.USD","BK1554","HGmain","BK1522","GDX","IE00BZ08YT58.USD","NUGT","BK1116","BK1238","SGCmain","SGUmain","00868","BK1196","01072","BK1205","BK1546","BK1561","LU1064131003.USD","518880","HK0000252152.HKD","BK1500","BK1583","BK1100","IE00BZ08YR35.GBP","SImain","08328","BK1589","BK1604","02235","LU1064130708.USD","00968","00900","HK0000252160.HKD","DUST","GCmain","IE00BZ08YS42.EUR","IAU","LU2148510915.USD","BK1188","BK1594","00512","03868","159934","PLmain"],"gpt_icon":1},{"id":"2593474493","title":"远大医药(00512)引进全球首款用于治疗严重过敏反应的肾上腺素鼻喷雾剂","url":"https://stock-news.laohu8.com/highlight/detail?id=2593474493","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593474493?lang=zh_cn&edition=full","pubTime":"2025-12-23 17:07","pubTimestamp":1766480850,"startTime":"0","endTime":"0","summary":"集团将获得全球首款用于紧急治疗成人和 30kg 及以上儿童患者以及 15-30kg 儿童患者I 型过敏反应的肾上腺素鼻喷雾剂 Neffy 在中国大陆合作渠道内的独家商业化权益以及在中国香港特别行政区的非独家商业化权益。此次,集团引进的全球创新肾上腺素鼻喷雾剂优敏速是 35 年来 FDA 首次批准的用于 I 型过敏反应的非注射治疗产品,有望提高肾上腺素治疗产品对中国严重过敏反应患者的可及性,并填补严重过敏反应急救药物在院外场景使用的空白。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1384928.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1191","00512"],"gpt_icon":0},{"id":"2593208452","title":"每日卖空追踪 | 远大医药 12月22日卖空量成交17.2万股,卖空比例为4.51%","url":"https://stock-news.laohu8.com/highlight/detail?id=2593208452","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593208452?lang=zh_cn&edition=full","pubTime":"2025-12-22 16:30","pubTimestamp":1766392213,"startTime":"0","endTime":"0","summary":"远大医药北京时间12月22日,涨1.34%,卖空量成交17.2万股,较上一交易日减少77.29%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251222163229a46992bf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251222163229a46992bf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["00512","BK1191"],"gpt_icon":0},{"id":"2593943679","title":"远大医药12月22日获主力加仓94.0万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2593943679","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593943679?lang=zh_cn&edition=full","pubTime":"2025-12-22 16:16","pubTimestamp":1766391366,"startTime":"0","endTime":"0","summary":"12月22日, 远大医药股价涨1.34%,报收8.30元,成交金额3162.4万元,换手率0.11%,振幅1.34%,量比0.58。远大医药今日主力资金净流入94.0万元,上一交易日主力净流入573.4万元。该股近5个交易日上涨1.22%,主力资金累计净流出1085.7万元;近20日主力资金累计净流入373.6万元,其中净流入天数为11日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251222162426a6c08e7d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251222162426a6c08e7d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","00512"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.chinagrandpharm.com","stockEarnings":[{"period":"1week","weight":0.0128},{"period":"1month","weight":-0.0259},{"period":"3month","weight":-0.0562},{"period":"6month","weight":-0.1478},{"period":"1year","weight":0.8571},{"period":"ytd","weight":0.0064}],"compareEarnings":[{"period":"1week","weight":-0.0041},{"period":"1month","weight":0.0271},{"period":"3month","weight":-0.0022},{"period":"6month","weight":0.0867},{"period":"1year","weight":0.3633},{"period":"ytd","weight":0.0235}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"远大医药健康控股有限公司是一家主要从事制造及销售医药制剂及医疗器械的香港投资控股公司。该公司主要从事制造及销售医药制剂及医疗器械、生物技术产品及营养产品、精品原料药和其他产品。该公司的主要产品涵盖抗肿瘤、心血管急救制剂及高端心脑血管介入医疗器械、抗病毒抗感染、呼吸及五官科以及生物健康产品和精品原料药。","yearOnYearQuotes":[{"month":1,"riseRate":0.483871,"avgChangeRate":0.08443},{"month":2,"riseRate":0.7,"avgChangeRate":0.108479},{"month":3,"riseRate":0.4,"avgChangeRate":0.019078},{"month":4,"riseRate":0.633333,"avgChangeRate":0.018767},{"month":5,"riseRate":0.466667,"avgChangeRate":0.084333},{"month":6,"riseRate":0.366667,"avgChangeRate":-0.048262},{"month":7,"riseRate":0.366667,"avgChangeRate":-0.015905},{"month":8,"riseRate":0.4,"avgChangeRate":0.007133},{"month":9,"riseRate":0.466667,"avgChangeRate":-0.039275},{"month":10,"riseRate":0.5,"avgChangeRate":-0.014834},{"month":11,"riseRate":0.5,"avgChangeRate":0.085694},{"month":12,"riseRate":0.5,"avgChangeRate":-0.007596}],"exchange":"SEHK","name":"远大医药","nameEN":"GRAND PHARMA"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.0","shortVersion":"4.36.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"远大医药(00512)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供远大医药(00512)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"远大医药,00512,远大医药股票,远大医药股票老虎,远大医药股票老虎国际,远大医药行情,远大医药股票行情,远大医药股价,远大医药股市,远大医药股票价格,远大医药股票交易,远大医药股票购买,远大医药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"远大医药(00512)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供远大医药(00512)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}